On July 15, 2025, XRP Healthcare announced the execution of a Definitive Agreement with AAJ Capital 3 Corp. (TSXV: AAAJ.P) a significant step in the company’s plan to complete a Qualifying Transaction and seek a listing on the TSX Venture Exchange (TSXV), pending customary regulatory and shareholder approvals.
More Than a Milestone A Commitment to Standards
This development is not about headlines or short-term positioning. It reflects XRP Healthcare’s focus on accountability, structured growth, and transparent operations principles that align with our long-term strategy.
Why Enter Public Markets?
A public listing demands greater scrutiny, and we welcome that rigor. Far from a constraint, it reinforces our ability to create durable value by introducing:
-
Audited financial reporting and expanded disclosure obligations
-
Internal control frameworks aligned with COSO standards
-
Corporate governance protocols under TSXV Policy 2.4
-
Stronger oversight through an independent board
-
Enhanced investor protection supported by regulatory transparency
These requirements aren’t obstacles; they are mechanisms that enable resilience and trust.
A Clear Message to Stakeholders
This move is not about following trends. It signals to investors, strategic partners, and institutional audiences that XRP Healthcare is building a platform with substance, not speculation.
From our pharmacy acquisitions in Uganda to scaling an AI-driven healthcare application across diverse linguistic markets and extending to our U.S. prescription savings card network that includes over 68,000 pharmacies such as CVS, Walgreens, and Walmart each initiative is rooted in tangible, measurable outcomes.
Entering a Higher Standard By Choice
We view public-market discipline as a catalyst for progress. For XRP Healthcare, this transition is not an end goal it’s the foundation for the next phase of sustainable expansion.
Forward-Looking Information
This communication includes forward-looking statements under applicable securities laws. Such statements relate to the anticipated Qualifying Transaction with AAJ Capital 3 Corp., expected benefits of becoming publicly listed, and projected growth strategies. These statements are based on current assumptions and are subject to various risks and uncertainties that may cause actual results to differ materially. Completion of the transaction is not guaranteed and remains subject to regulatory review and TSX Venture Exchange approval. Readers should avoid placing undue reliance on these statements. XRP Healthcare undertakes no obligation to update forward-looking information unless required by law.